Captor Therapeutics Spolka Akcyjna Future Growth
Future criteria checks 6/6
Captor Therapeutics Spolka Akcyjna is forecast to grow earnings and revenue by 71.9% and 30.2% per annum respectively. EPS is expected to grow by 57% per annum. Return on equity is forecast to be 104.1% in 3 years.
Key information
71.9%
Earnings growth rate
57.0%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 30.2% |
| Future return on equity | 104.1% |
| Analyst coverage | Low |
| Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Here's Why We're Not Too Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation
Jul 13
We Think Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Drive Business Growth
Mar 10We're Not Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn
Oct 03Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation
Mar 13Companies Like Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Invest In Growth
Jun 15Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 50 | -18 | 6 | -6 | 2 |
| 12/31/2025 | 65 | 4 | -24 | 3 | 2 |
| 12/31/2024 | 21 | -44 | -52 | -35 | 3 |
| 9/30/2024 | 19 | -41 | -41 | -41 | N/A |
| 6/30/2024 | 19 | -47 | -40 | -38 | N/A |
| 3/31/2024 | 16 | -66 | -58 | -55 | N/A |
| 12/31/2023 | 13 | -71 | -55 | -52 | N/A |
| 9/30/2023 | 13 | -66 | -40 | -37 | N/A |
| 6/30/2023 | 11 | -58 | -43 | -41 | N/A |
| 3/31/2023 | 10 | -39 | -26 | -25 | N/A |
| 12/31/2022 | 9 | -36 | -24 | -23 | N/A |
| 9/30/2022 | 5 | -40 | -32 | -26 | N/A |
| 6/30/2022 | 5 | -41 | -32 | -27 | N/A |
| 3/31/2022 | 5 | -38 | -29 | -24 | N/A |
| 12/31/2021 | 4 | -33 | -34 | -28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CTX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (4.1%).
Earnings vs Market: CTX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CTX is expected to become profitable in the next 3 years.
Revenue vs Market: CTX's revenue (30.2% per year) is forecast to grow faster than the Polish market (4% per year).
High Growth Revenue: CTX's revenue (30.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CTX's Return on Equity is forecast to be very high in 3 years time (104.1%).